Role of some neurohumoral factors in development of pulmonary hypertension in patients with interstitial lung diseases

被引:0
|
作者
Arkhipova, DV [1 ]
Kornev, BM
Popova, EN
Kogan, EA
Osipenko, VI
Privalova, EV
Kobylensky, AG
Mescheryakova, SA
Efremov, EE
机构
[1] IM Sechenov Med Acad, Moscow, Russia
[2] Russian Cardiol Sci Ind Complex, Moscow, Russia
关键词
pulmonary hypertension; alveolitis; nitric oxide; histamine; angiotensin-converting enzyme;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To ascertain the role of some neurohumoral factors - nitric oxide (NO), ACE, histamine - in development of pulmonary hypertension (PH) in patients with interstitial lung diseases (ILD). Material and methods. A total of 32 ILD patients were examined. Of them 14 had idiopathic fibrosing alveolitis (IFA), 6 had exogenous allergic alveolitis (EAA) and 12 patients had ILD in diffuse disease of the connective tissue (ILD-DDCT). In addition to routine tests, those for NO, ACE, histamine, serotonin in plasma, were performed; Doppler echocardiography and high-resolution computed tomography were conducted. In 9 patients the diagnosis was verified at thoracoscopic biopsy of the lung. The control group consisted of 16 healthy subjects. Results. The highest, mean pressure in the pulmonary, artery (PmPA) was registered in IFA vs EAA and ILD-DDCT patients (p < 0.001). NO concentration in plasma was higher in ILD-DDCT than in control patients. In MA and EAA the level of NO was like in controls. Concentration of NO in plasma of IDL patients correlated with high activity of the process. No correlation was found between ACE in. plasma and PmPA, ACE levels were much higher in controls than in the ILD patients (p < 0.05). Histamine levels were higher in ILD patients than in controls being the-highest in ILD-DDCT Serotonin was insignificantly higher in ILD patients than in controls. Conclusion. Damage to the endothelium of the pulmonary arteries and imbalance of neurohumoral factors may be considered as a mechanism of development and stabilization of PH in ILD patients.
引用
收藏
页码:44 / 49
页数:6
相关论文
共 50 条
  • [11] Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease and Interstitial Lung Diseases
    Weitzenblum, Emmanuel
    Chaouat, Ari
    Canuet, Matthieu
    Kessler, Romain
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 30 (04) : 458 - 470
  • [12] Pulmonary hypertension in patients with interstitial lung disease
    Karampitsakos, Theodoros
    Tzouvelekis, Argyrios
    Chrysikos, Serafeim
    Bouros, Demosthenes
    Tsangaris, Iraklis
    Fares, Wassim H.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 50 : 38 - 46
  • [13] Risk factors of pulmonary hypertension in interstitial lung disease
    Ang, H.
    Schulte, M.
    Chan, R.
    Tan, H.
    Harrison, A.
    Ryerson, C.
    Khor, Y.
    RESPIROLOGY, 2024, 29 : 80 - 80
  • [14] Some mechanisms of pulmonary hypertension development in patients with chronic obstructive pulmonary diseases
    Karoli, NA
    Rebroy, AP
    TERAPEVTICHESKII ARKHIV, 2005, 77 (03) : 87 - 93
  • [15] Hospital Outcomes Among Patients Admitted with Pulmonary Hypertension Due to Interstitial Lung Diseases
    Chaparro, S.
    Rubens, M.
    Roy, M.
    Saxena, A.
    Vaidean, G.
    Jimenez, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S315 - S316
  • [16] Identifying pulmonary hypertension in newly recognized interstitial lung diseases - a role of new scoring system
    Sobiecka, Malgorzata
    Lewandowska, Katarzyna
    Kober, Jaroslaw
    Franczuk, Monika
    Skoczylas, Agnieszka
    Tomkowski, Witold
    Kus, Jan
    Szturmowicz, Monika
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [17] ENDOTHELIN-1 AND BRAIN NATRIURETIC PEPTIDE IN THE DEVELOPMENT OF PULMONARY HYPERTENSION IN INTERSTITIAL LUNG DISEASES
    Fomin, V. V.
    Popova, E. N.
    Kuznetsova, A. V.
    Popova, I. A.
    Churganova, L. Yu.
    Osipenko, V. I.
    Mukhin, N. A.
    TERAPEVTICHESKII ARKHIV, 2009, 81 (12) : 58 - 63
  • [18] Defining a pathological role for the vasculature in the development of fibrosis and pulmonary hypertension in interstitial lung disease
    George, Peter M.
    Mitchell, Jane A.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2019, 317 (04) : L431 - L433
  • [19] Predictors of Pulmonary Hypertension in Patients With Interstitial Lung Disease
    Pannu, G.
    Pritchard, D.
    Sood, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [20] Relationship of hypoxia induced by daily living and pulmonary arterial hypertension in patients with interstitial lung diseases
    Kim, Doug Soon
    Park, Jeong Hyun
    Jegal, Yang Jin
    Park, I-Nae
    Shim, Tae Sun
    Lim, Chae-Man
    Do Lee, Sang
    Koh, Younsuk
    Kim, Woo Sung
    Kim, Won Dong
    CHEST, 2007, 132 (04) : 429S - 429S